Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT06747949 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT06747949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Recruiting
Start date
February 25, 2025
Completion date
December 11, 2029
Enrollment
844 (estimated)
Sites
174

Conditions

As the registry lists them; a condition with its own page is linked.

sjögren's syndrome